Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
about
The crosstalk of mTOR/S6K1 and Hedgehog pathwaysThe mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trialsSignaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionSignaling cross-talk in the resistance to HER family receptor targeted therapyDeoxycholic acid induces the overexpression of intestinal mucin, MUC2, via NF-kB signaling pathway in human esophageal adenocarcinoma cells.History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancerHepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinomaProinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors.Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.Rapamycin and thalidomide treatment of a patient with refractory metastatic gastroesophageal adenocarcinoma: a case report.IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression.A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascadeCranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation.Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo.Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer.TNFalpha induces HIF-1alpha expression through activation of IKKbetaSystematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia.Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas.A third-generation herpesvirus is effective against gastroesophageal cancer.Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis.Cholecystectomy as a risk factor for oesophageal adenocarcinoma.Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2.Bile acids: a potential role in the pathogenesis of pharyngeal malignancy.The activation of mTOR is required for monocyte pro-inflammatory response in patients with coronary artery disease.Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein Activation
P2860
Q24308749-283A5358-31F8-4ADE-8AB4-A34FB9DB8569Q26751155-848FBD9D-464B-43EC-88F7-72D28C389ED9Q27026253-3D56EBBE-26F9-4A4F-99B0-A006355E8C2FQ27027778-BCFB2E35-6963-4980-B038-98AC5C26CF7AQ33384875-ABDE0A5E-39D9-4092-B32E-D37ECAA32559Q33786336-8014C921-E1E4-4277-B1BF-3A6EA82E7BA5Q33882085-F6B99AAE-87FB-41CC-AD48-E33F31789F1BQ34359262-0F89AA7C-15DB-426C-8B93-9CB1B5016A93Q34745663-A7085D84-5BB7-4EEB-B018-F1AB6293F27FQ35185711-B70486F0-A8F4-48D5-823B-330F722132A4Q35584253-15C40C8E-3D0E-4DC6-872B-1C4A7AA4BE40Q35713747-1EDB5ED7-3B79-41F8-9B4C-3A13B3463233Q36279164-7DC212A3-A1EB-4F33-A3A3-1CFBC6EEBCA8Q36432388-1FFE4E1A-6AF7-4B64-85BB-C85AB0FEC32AQ36545177-5B5F3FE8-4580-40B7-A69C-3D6267C9AEB3Q36681744-25934DED-0EBE-4142-89F6-08BE2F1DDC84Q37015667-4E1CB77C-978D-45E7-8D13-5611A84D7214Q37387690-EE40B5C4-8E6A-4D06-A7A7-60C39191634DQ37880176-BF2E049C-02ED-4972-A5B9-58319FB173A8Q38388948-A74A47E7-F550-4977-AA86-B1D00C4F0D62Q39694724-3FA158F8-8422-4FB7-8628-9D0FF48CE57DQ42053613-203E9B21-DB03-4189-A25D-C9D64B77677AQ45141122-53AE8B83-CDBA-42BE-ABD9-F5C51E18E3F6Q47104365-85B878B9-C071-4DCA-B8AD-3F7622D40C35Q48106135-64DA3B60-CAC8-4C36-973E-EA5D626155D1Q51312253-B75EDA3F-88F1-4CAD-B473-D086F1F6E532Q57109201-2CFD878A-55F2-452C-BDBE-C75A8F7F7DCF
P2860
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Bile acid exposure up-regulate ...... ted esophageal adenocarcinoma.
@ast
Bile acid exposure up-regulate ...... ted esophageal adenocarcinoma.
@en
type
label
Bile acid exposure up-regulate ...... ted esophageal adenocarcinoma.
@ast
Bile acid exposure up-regulate ...... ted esophageal adenocarcinoma.
@en
prefLabel
Bile acid exposure up-regulate ...... ted esophageal adenocarcinoma.
@ast
Bile acid exposure up-regulate ...... ted esophageal adenocarcinoma.
@en
P2093
P2860
P1433
P1476
Bile acid exposure up-regulate ...... ated esophageal adenocarcinoma
@en
P2093
Chao-Kai Chou
Chia-Jui Yen
Chun-Te Chen
Hsu-Ping Kuo
Hui-Lung Sun
Jaffer Ajani
Julie G Izzo
Jung-Mao Hsu
Kenneth K Wang
Mien-Chie Hung
P2860
P304
P356
10.1158/0008-5472.CAN-07-5460
P407
P577
2008-04-01T00:00:00Z